666

MEDEON BIODESIGN INC

No trades
See on Supercharts
Market capitalization
‪3.88 B‬TWD
−13.10TWD
‪−1.20 B‬TWD
‪196.26 M‬TWD
‪33.12 M‬
Beta (1Y)
0.08

About MEDEON BIODESIGN INC

CEO
Yu Te Chang
Headquarters
Taipei
Founded
2012
ISIN
TW0006499007
FIGI
BBG007NPQT83
Medeon Biodesign, Inc. engages in the development, manufacture, and sale of medical equipment. It specializes in minimally invasive surgery products. The company’s products include minimally invasive laparoscopic surgery and minimally invasive cardiac catheterization surgery related medical equipment. Medeon Biodesign was founded on December 22, 2012 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6499 is 42.25 TWD — it has increased by 0.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MEDEON BIODESIGN INC stocks are traded under the ticker 6499.
MEDEON BIODESIGN INC is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
6499 stock is 1.07% volatile and has beta coefficient of 0.08. Check out the list of the most volatile stocks — is MEDEON BIODESIGN INC there?
6499 earnings for the last quarter are −0.67 TWD per share, whereas the estimation was −0.68 TWD resulting in a 1.06% surprise. The estimated earnings for the next quarter are −1.12 TWD per share. See more details about MEDEON BIODESIGN INC earnings.
MEDEON BIODESIGN INC revenue for the last quarter amounts to ‪139.00 M‬ TWD despite the estimated figure of ‪139.00 M‬ TWD. In the next quarter revenue is expected to reach ‪7.00 M‬ TWD.
Yes, you can track MEDEON BIODESIGN INC financials in yearly and quarterly reports right on TradingView.
6499 stock has fallen by 1.29% compared to the previous week, the month change is a 3.21% fall, over the last year MEDEON BIODESIGN INC has showed a 22.17% decrease.
6499 net income for the last quarter is ‪−204.62 M‬ TWD, while the quarter before that showed ‪−193.73 M‬ TWD of net income which accounts for −5.62% change. Track more MEDEON BIODESIGN INC financial stats to get the full picture.
Today MEDEON BIODESIGN INC has the market capitalization of ‪3.88 B‬, it has increased by 1.27% over the last week.
Yes, 6499 dividends are paid annually. The last dividend per share was 0.50 TWD. As of today, Dividend Yield (TTM)% is 1.07%. Tracking MEDEON BIODESIGN INC dividends might help you take more informed decisions.
Like other stocks, 6499 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDEON BIODESIGN INC stock right from TradingView charts — choose your broker and connect to your account.
6499 reached its all-time high on Dec 18, 2015 with the price of 192.65 TWD, and its all-time low was 3.30 TWD and was reached on Dec 11, 2014.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDEON BIODESIGN INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDEON BIODESIGN INC stock shows the strong sell signal. See more of MEDEON BIODESIGN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDEON BIODESIGN INC EBITDA is ‪−743.84 M‬ TWD, and current EBITDA margin is −379.03%. See more stats in MEDEON BIODESIGN INC financial statements.